Devika A Shenoy, Abigail VanLonkhuyzen, Bradley Q Fox, Sabrina M Morales, Sai H Rachakonda, Gina Upchurch, Anna Hung
{"title":"Addressing complexity: The development and pilot testing of a user-friendly Medicare Part D patient decision aid tool.","authors":"Devika A Shenoy, Abigail VanLonkhuyzen, Bradley Q Fox, Sabrina M Morales, Sai H Rachakonda, Gina Upchurch, Anna Hung","doi":"10.18553/jmcp.2025.31.9.868","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Selecting a Medicare Part D prescription drug plan can be challenging because of limited health insurance literacy and complex plan features. Existing online tools, such as the Medicare Plan Finder (MPF), often lack personalization.</p><p><strong>Objective: </strong>To describe the conceptualization and development of a personalized Medicare Part D decision aid (DA) to supplement the MPF.</p><p><strong>Methods: </strong>A user-centered, iterative design process informed by the Ottawa Decision Support Framework and International Patient Decision Aid Standards was used to develop a DA that helps older adults with Part D plan selection. First, a literature review and 1-hour interviews with Medicare-eligible individuals informed the development of a prototype. These individuals formed a stakeholder advisory board (SAB). The first prototype was then alpha tested with 2 SAB focus groups. Using focus group feedback, the final prototype was developed. Beta testing participants, including Medicare-eligible individuals and Medicare counselors, were recruited and completed an online version of the DA, alongside pre-DA and post-DA questionnaires to examine DA effectiveness using a modified Health Insurance Literacy Measure, a modified System Usability Scale, and a user satisfaction survey.</p><p><strong>Results: </strong>Before the development of the prototype, SAB interviewees (n = 9) suggested that simplified explanations of insurance terminology and side-by-side comparisons of options would be important to the DA. Alpha testing (n = 7) feedback was used to modify the first prototype to improve usability and clarity. Among 25 beta testing participants, Health Insurance Literacy Measure scores increased from 19.76 (SD = 7.15) before using the aid to 24.13 (SD = 4.02) afterward (<i>P</i> = 0.0009). Approximately one-quarter of participants indicated that they would change to a new plan after the tool, whereas half affirmed that the DA validated their existing plan choice.</p><p><strong>Conclusions: </strong>This pilot study shows that a user-centered, interactive DA can improve health insurance literacy and support Medicare Part D plan decisions.</p>","PeriodicalId":16170,"journal":{"name":"Journal of managed care & specialty pharmacy","volume":"31 9","pages":"868-878"},"PeriodicalIF":2.9000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12398625/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of managed care & specialty pharmacy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18553/jmcp.2025.31.9.868","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Selecting a Medicare Part D prescription drug plan can be challenging because of limited health insurance literacy and complex plan features. Existing online tools, such as the Medicare Plan Finder (MPF), often lack personalization.
Objective: To describe the conceptualization and development of a personalized Medicare Part D decision aid (DA) to supplement the MPF.
Methods: A user-centered, iterative design process informed by the Ottawa Decision Support Framework and International Patient Decision Aid Standards was used to develop a DA that helps older adults with Part D plan selection. First, a literature review and 1-hour interviews with Medicare-eligible individuals informed the development of a prototype. These individuals formed a stakeholder advisory board (SAB). The first prototype was then alpha tested with 2 SAB focus groups. Using focus group feedback, the final prototype was developed. Beta testing participants, including Medicare-eligible individuals and Medicare counselors, were recruited and completed an online version of the DA, alongside pre-DA and post-DA questionnaires to examine DA effectiveness using a modified Health Insurance Literacy Measure, a modified System Usability Scale, and a user satisfaction survey.
Results: Before the development of the prototype, SAB interviewees (n = 9) suggested that simplified explanations of insurance terminology and side-by-side comparisons of options would be important to the DA. Alpha testing (n = 7) feedback was used to modify the first prototype to improve usability and clarity. Among 25 beta testing participants, Health Insurance Literacy Measure scores increased from 19.76 (SD = 7.15) before using the aid to 24.13 (SD = 4.02) afterward (P = 0.0009). Approximately one-quarter of participants indicated that they would change to a new plan after the tool, whereas half affirmed that the DA validated their existing plan choice.
Conclusions: This pilot study shows that a user-centered, interactive DA can improve health insurance literacy and support Medicare Part D plan decisions.
期刊介绍:
JMCP welcomes research studies conducted outside of the United States that are relevant to our readership. Our audience is primarily concerned with designing policies of formulary coverage, health benefit design, and pharmaceutical programs that are based on evidence from large populations of people. Studies of pharmacist interventions conducted outside the United States that have already been extensively studied within the United States and studies of small sample sizes in non-managed care environments outside of the United States (e.g., hospitals or community pharmacies) are generally of low interest to our readership. However, studies of health outcomes and costs assessed in large populations that provide evidence for formulary coverage, health benefit design, and pharmaceutical programs are of high interest to JMCP’s readership.